Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Protein oxidation in the brain in Alzheimer's disease

Producción científica: Articlerevisión exhaustiva

469 Citas (Scopus)

Resumen

In this study we used immunohistochemistry and two-dimensional fingerprinting of oxidatively modified proteins (two-dimensional Oxyblot) together to investigate protein carbonyl formation in the Alzheimer's disease brain. Increased protein oxidation was detected in sections from the hippocampus and parahippocampal gyrus, superior and middle temporal gyri of six Alzheimer's disease and six age-matched control human subjects, but not in the cerebellum. In two brain regions severely affected by Alzheimer's disease pathology, prominent protein carbonyl immunoreactivity was localized in the cytoplasm of neurons without visual pathomorphological changes and degenerating neurons, suggesting that intracellular proteins might be significantly affected by oxidative modifications. Following two-dimensional electrophoresis the positions of some individual proteins were identified using specific antibodies, and immunoblot analysis for protein carbonyls was performed. These studies demonstrated the presence of protein carbonyl immunoreactivity in β-tubulin, β-actin and creatine kinase BB in Alzheimer's disease and control brain extracts. Protein carbonyls were undetectable in spots matching glial fibrillary acidic protein and tau isoforms. Specific protein carbonyl levels in β-actin and creatine kinase BB were significantly higher in Alzheimer's disease than in control brain extract. β-Tubulin did not demonstrate a significant increase in specific protein carbonyl content in Alzheimer's disease brains. We suggest that oxidative stress-induced injury may involve the selective modification of different intracellular proteins, including key enzymes and structural proteins, which precedes and may lead to the neurofibrillary degeneration of neurons in the Alzheimer's disease brain.

Idioma originalEnglish
Páginas (desde-hasta)373-383
Número de páginas11
PublicaciónNeuroscience
Volumen103
N.º2
DOI
EstadoPublished - mar 14 2001

Nota bibliográfica

Funding Information:
This work was supported by NIH grants 5P01 AG05119, 5P50 AG05144, and grants from the Abercrombie Foundation and the Kleberg Foundation. The authors thank Dianna Tudor and Ela Patel for technical assistance, Jane Meara and Paula Thomason for assistance in manuscript preparation, and Cecil Runyons for subject demographic data. The authors also thank Elan Pharmaceutical for the gift of antibodies.

Financiación

This work was supported by NIH grants 5P01 AG05119, 5P50 AG05144, and grants from the Abercrombie Foundation and the Kleberg Foundation. The authors thank Dianna Tudor and Ela Patel for technical assistance, Jane Meara and Paula Thomason for assistance in manuscript preparation, and Cecil Runyons for subject demographic data. The authors also thank Elan Pharmaceutical for the gift of antibodies.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)5P01 AG05119
National Institute on AgingP50AG005144
Abercrombie Foundation
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • General Neuroscience

    Huella

    Profundice en los temas de investigación de 'Protein oxidation in the brain in Alzheimer's disease'. En conjunto forman una huella única.

    Citar esto